Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Cincinnati pediatricians' measured and reported immunizing behavior for children during the national shortages of pneumococcal conjugate vaccine.

Fairbrother G, Donauer S, Staat MA, Broder K, Salisbury S, Morrow AL, Tabangin ME, Altaye M, Holloway M, Schwartz B.

Vaccine. 2013 Apr 19;31(17):2177-83. doi: 10.1016/j.vaccine.2013.02.038. Epub 2013 Mar 6.

PMID:
23474316
2.

Who's calling the shots? Pediatricians' adherence to the 2001-2003 pneumococcal conjugate vaccine-shortage recommendations.

Broder KR, MacNeil A, Malone S, Schwartz B, Baughman AL, Murphy TV, Pickering LK, Moran JS.

Pediatrics. 2005 Jun;115(6):1479-87.

PMID:
15930207
3.

Pediatricians' adherence to pneumococcal conjugate vaccine shortage recommendations in 2 national shortages.

Fairbrother G, Broder K, Staat MA, Schwartz B, Heubi C, Hiratzka S, Walker FJ, Morrow AL.

Pediatrics. 2007 Aug;120(2):e401-9. Epub 2007 Jul 23.

PMID:
17646354
4.

Temporary vaccine recommendations and provider compliance: a survey of pediatric practices during the 2003-2004 pneumococcal conjugate vaccine shortage.

Groom H, Bhatt A, Washington ML, Santoli J.

Pediatrics. 2008 Oct;122(4):e835-40. doi: 10.1542/peds.2008-1092.

PMID:
18829781
5.

Influence of insurance status and vaccine cost on physicians' administration of pneumococcal conjugate vaccine.

Davis MM, Ndiaye SM, Freed GL, Kim CS, Clark SJ.

Pediatrics. 2003 Sep;112(3 Pt 1):521-6.

PMID:
12949277
6.

Effect of vaccine shortages on timeliness of pneumococcal conjugate vaccination: results from the 2001-2005 National Immunization Survey.

Smith PJ, Nuorti JP, Singleton JA, Zhao Z, Wolter KM.

Pediatrics. 2007 Nov;120(5):e1165-73.

PMID:
17974712
7.

Using registry data to evaluate the 2004 pneumococcal conjugate vaccine shortage.

Allred NJ, Stevenson JM, Kolasa M, Bartlett DL, Schieber R, Enger KS, Shefer A.

Am J Prev Med. 2006 Apr;30(4):347-50.

PMID:
16530623
8.

Physician compliance with pneumococcal conjugate vaccine shortage recommendations in 2004.

Kolasa MS, Tannenbaum SM, Stevenson JM.

J Public Health Manag Pract. 2007 Nov-Dec;13(6):578-83.

PMID:
17984711
9.

One-year uptake of pneumococcal conjugate vaccine: a national survey of family physicians and pediatricians.

Davis MM, Ndiaye SM, Freed GL, Clark SJ.

J Am Board Fam Pract. 2003 Sep-Oct;16(5):363-71.

10.

Uptake of pneumococcal conjugate vaccine among children in the 1998-2002 United States birth cohorts.

Nuorti JP, Martin SW, Smith PJ, Moran JS, Schwartz B.

Am J Prev Med. 2008 Jan;34(1):46-53.

PMID:
18083450
12.

Pediatricians' self-reported clinical practices and adherence to national immunization guidelines after the introduction of pneumococcal conjugate vaccine.

Lee KC, Finkelstein JA, Miroshnik IL, Rusinak D, Santoli JM, Lett SM, Lieu TA.

Arch Pediatr Adolesc Med. 2004 Jul;158(7):695-701.

PMID:
15237070
13.

Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.

Lacapa R, Bliss SJ, Larzelere-Hinton F, Eagle KJ, McGinty DJ, Parkinson AJ, Santosham M, Craig MJ, O'Brien KL.

Clin Infect Dis. 2008 Aug 15;47(4):476-84. doi: 10.1086/590001.

PMID:
18627249
14.

Recommendations for the prevention of Streptococcus pneumoniae infections in infants and children: use of 13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23).

American Academy of Pediatrics Committee on Infectious Diseases.

Pediatrics. 2010 Jul;126(1):186-90. doi: 10.1542/peds.2010-1280. Epub 2010 May 24.

PMID:
20498180
15.

Provider adoption of pneumococcal conjugate vaccine and the impact of vaccine shortages.

Daley MF, Crane LA, Beaty BL, Barrow J, Pearson K, Stevenson JM, Berman S, Kempe A.

Ambul Pediatr. 2005 May-Jun;5(3):157-64.

PMID:
15913409
16.

Increase in invasive pneumococcal disease in children associated with shortage of heptavalent pneumococcal conjugate vaccine.

Abuelreish M, Subedar A, Chiu T, Wludyka P, Rathore M.

Clin Pediatr (Phila). 2007 Jan;46(1):45-52.

PMID:
17164509
17.

Physician perspectives regarding pneumococcal conjugate vaccine.

Schaffer SJ, Szilagyi PG, Shone LP, Ambrose SJ, Dunn MK, Barth RD, Edwards K, Weinberg GA, Balter S, Schwartz B.

Pediatrics. 2002 Dec;110(6):e68.

PMID:
12456935
18.

Impact of state vaccine financing policy on uptake of heptavalent pneumococcal conjugate vaccine.

Stokley S, Shaw KM, Barker L, Santoli JM, Shefer A.

Am J Public Health. 2006 Jul;96(7):1308-13. Epub 2006 May 30.

19.

Safety and effectiveness against respiratory tract infections for pneumococcal conjugate vaccine co-administered with routine vaccine combinations.

Adam D, Fehnle K.

Vaccine. 2008 Nov 5;26(47):5944-51. doi: 10.1016/j.vaccine.2008.08.058. Epub 2008 Sep 16.

PMID:
18801402
20.

Supplemental Content

Support Center